TWST - Twist Bioscience Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
24.05
-2.61 (-9.79%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close26.66
Open26.62
Bid21.51 x 3000
Ask26.21 x 800
Day's Range22.28 - 26.75
52 Week Range12.38 - 29.21
Volume235,599
Avg. Volume300,992
Market Cap639.97M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-25.57
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire20 days ago

    Twist Bioscience Corporation Announces Pricing of Initial Public Offering

    Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on October 31, 2018 under the ticker symbol “TWST.” The closing of the offering is expected to occur on November 2, 2018, subject to customary closing conditions. In addition, Twist has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the initial public offering price, less the underwriting discounts and commissions.

  • Business Wire21 days ago

    Twist Bioscience Corporation Announces Pricing of Initial Public Offering

    Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on October 31, 2018 under the ticker symbol “TWST.” The closing of the offering is expected to occur on November 2, 2018, subject to customary closing conditions. In addition, Twist has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the initial public offering price, less the underwriting discounts and commissions.

  • Benzinga23 days ago

    IPO Outlook For The Week: Banks And Biotechs

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . IPO dates are expected, not confirmed, at time of publication. BankFlorida (BFL) will issue 6.2 million shares between ...